Published in Hepatitis Weekly, May 12th, 2003
The finding, published online in ScienceExpress, could lead to more effective treatments for liver disease caused by hepatitis C virus, said author Michael Gale Jr., PhD, of University of Texas Southwestern Medical Center at Dallas. Gale and coauthor Stanley Lemon, MD, of University of Texas Medical Branch at Galveston, are grantees of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
"Persistent hepatitis C virus (HCV) infection is a major cause of liver disease worldwide and is the leading reason for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.